Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tau isoform expression and phosphorylation in marmoset brains.
Sharma G, Huo A, Kimura T, Shiozawa S, Kobayashi R, Sahara N, Ishibashi M, Ishigaki S, Saito T, Ando K, Murayama S, Hasegawa M, Sobue G, Okano H, Hisanaga SI. Sharma G, et al. Among authors: hasegawa m. J Biol Chem. 2019 Jul 26;294(30):11433-11444. doi: 10.1074/jbc.RA119.008415. Epub 2019 Jun 5. J Biol Chem. 2019. PMID: 31171723 Free PMC article.
Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.
Hasegawa M, Fujiwara H, Nonaka T, Wakabayashi K, Takahashi H, Lee VM, Trojanowski JQ, Mann D, Iwatsubo T. Hasegawa M, et al. J Biol Chem. 2002 Dec 13;277(50):49071-6. doi: 10.1074/jbc.M208046200. Epub 2002 Oct 10. J Biol Chem. 2002. PMID: 12377775 Free article.
alpha-Synuclein is one of the major components of intracellular fibrillary aggregates in the brains of a subset of neurodegenerative disorders, including Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and Hallervorden-Spatz disease, which are referred to …
alpha-Synuclein is one of the major components of intracellular fibrillary aggregates in the brains of a subset of neurodegenerative disorde …
Accumulation of phosphorylated alpha-synuclein in aging human brain.
Saito Y, Kawashima A, Ruberu NN, Fujiwara H, Koyama S, Sawabe M, Arai T, Nagura H, Yamanouchi H, Hasegawa M, Iwatsubo T, Murayama S. Saito Y, et al. Among authors: hasegawa m. J Neuropathol Exp Neurol. 2003 Jun;62(6):644-54. doi: 10.1093/jnen/62.6.644. J Neuropathol Exp Neurol. 2003. PMID: 12834109
Unique tauopathy in Fukuyama-type congenital muscular dystrophy.
Saito Y, Motoyoshi Y, Kashima T, Izumiyama-Shimomura N, Toda T, Nakano I, Hasegawa M, Murayama S. Saito Y, et al. Among authors: hasegawa m. J Neuropathol Exp Neurol. 2005 Dec;64(12):1118-26. doi: 10.1097/01.jnen.0000190069.10633.c2. J Neuropathol Exp Neurol. 2005. PMID: 16319722
Small molecule inhibitors of alpha-synuclein filament assembly.
Masuda M, Suzuki N, Taniguchi S, Oikawa T, Nonaka T, Iwatsubo T, Hisanaga S, Goedert M, Hasegawa M. Masuda M, et al. Among authors: hasegawa m. Biochemistry. 2006 May 16;45(19):6085-94. doi: 10.1021/bi0600749. Biochemistry. 2006. PMID: 16681381
4,135 results